Psyence Biomedical (Psyence Biomedical) Equity-to-Asset : -0.13 (As of Mar. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Psyence Biomedical's Total Stockholders Equity for the quarter that ended in Mar. 2023 was $-0.20 Mil. Psyence Biomedical's Total Assets for the quarter that ended in Mar. 2023 was $1.57 Mil.

The historical rank and industry rank for Psyence Biomedical's Equity-to-Asset or its related term are showing as below:

PBM' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.13 Med: 0.93 Max: 0.98
Current: -0.13

During the past 3 years, the highest Equity to Asset Ratio of Psyence Biomedical was 0.98. The lowest was -0.13. And the median was 0.93.

PBM's Equity-to-Asset is ranked worse than
85.75% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs PBM: -0.13

Psyence Biomedical Equity-to-Asset Historical Data

The historical data trend for Psyence Biomedical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Equity-to-Asset Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

Equity-to-Asset

0.98

0.93

-0.13

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
Equity-to-Asset	0.98	0.93	-0.13

Competitive Comparison of Psyence Biomedical's Equity-to-Asset

For the Biotechnology subindustry, Psyence Biomedical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Biomedical's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Equity-to-Asset falls into.

Psyence Biomedical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Psyence Biomedical's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-0.198	/	1.573
	=

Psyence Biomedical's Equity to Asset Ratio for the quarter that ended in Mar. 2023 is calculated as

Equity to Asset (Q: Mar. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-0.198	/	1.573
	=

Psyence Biomedical (NAS:PBM) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Psyence Biomedical Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024